Literature DB >> 22032085

Interpretation of correlations between coagulation factors FV, FVIII and vWF in normal and type 2 diabetes mellitus patients.

Mohammad Reza Dayer1, Maysam Mard-Soltani, Mohammad Saaid Dayer, Sayed Mohammad Reza Alavi.   

Abstract

Increased risk of vascular diseases in hypercoagulable states is assumed to be the major cause for prevalence of vascular problems in type 2 diabetes mellitus patient. The present study was undertaken to explore the basis underlying the correlation between the aforesaid three coagulation factors with reference to the relevant mechanistic findings using statistical calculation. Our findings showed that the correlation between each pairs of coagulation factors, FV, FVIII and vWF could be easily interpreted using previously characterized interactions between these factors. Also, given the sequence similarities between FV and FVIII as well as the results of this study, it was indicated, for the first time, that FV may bind to vWF in the same way as FVIII binds. This finding seems to be of great importance to be evaluated through experimental techniques.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22032085     DOI: 10.3923/pjbs.2011.552.557

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  3 in total

Review 1.  Diabetes mellitus and diabetic nephropathy: a review of the literature on hemostatic changes in coagulation and thrombosis.

Authors:  Ashwag Saleh Alsharidah
Journal:  Blood Res       Date:  2022-05-30

2.  Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.

Authors:  Hui Zhang; Chun Gao; Long Fang; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

3.  Causality relationships between coagulation factors in type 2 diabetes mellitus: path analysis approach.

Authors:  Mohammad Reza Dayer; Maysam Mard-Soltani; Mohammad Saaid Dayer; Sayed Mohammad Reza Alavi
Journal:  Med J Islam Repub Iran       Date:  2014-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.